France · 
Who invested in Amolyt Pharma?
Amolyt Pharma's investors include Intermediate Capital Group, Bpifrance, OrbiMed, Sofinnova Partners and EQT Life Sciences, and 1 more on record. Intermediate Capital Group led its latest round.
France · Series C startup
Who invested in Amolyt Pharma
Funding summaryUpdated 26 Oct 2026
$139Mraised across 1 round since 2023, from 2 sources
- Latest round
- Series C, $139MJan 2023
- Led by
- Intermediate Capital Group
- Investors
- 6 (1 led)
The rounds
- Jan 2023Series C$139M
Reported by Firms' own news pages and 1 other
Everyone who backed them
Intermediate Capital GroupGrowth equity1round, led 1
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Amolyt Pharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Amolyt Pharma
How much has Amolyt Pharma raised?
Amolyt Pharma has raised $139M across 1 round since 2023.
When did Amolyt Pharma last raise?
Amolyt Pharma's most recent round was a Series C of $139M in Jan 2023, led by Intermediate Capital Group.
What was Amolyt Pharma's biggest round?
Its most recent round, $139M in Jan 2023, is also its largest on record.
Who backed Amolyt Pharma first?
Amolyt Pharma's first round on record, in Jan 2023, was backed by Intermediate Capital Group, Bpifrance and OrbiMed and 3 others.
What stage is Amolyt Pharma at?
Amolyt Pharma's latest named round is a Series C, in Jan 2023.
Where is Amolyt Pharma based?
Amolyt Pharma is based in France.
Who led Amolyt Pharma's rounds?
Intermediate Capital Group led the Series C in 2023.
Companies like Amolyt Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.